GI
GILD
+3.8%🟢 Fundamentally supportedGilead Sciences Inc · Healthcare
$153.60Vol 5.73M · 1.0× normalMkt cap +$7.04Bafter · 2026-10-14 ET
What happened
Move
+3.8%
Price
$153.60
Volume
5.73M
1.0× normal
Market cap
$190.46B
+$7.04B today
Why it moved
Earnings releasemedium confidence
- Earnings Preview: What to Expect From Gilead Sciences’ Report — finnhub-news
- What Does Gilead Sciences (GILD) Gain From Its New Solid Tumor Partnership? — finnhub-news
Possible catalyst: earnings release, 2.5pp above its sector.
Verdict — was the move justified?
🟢 Fundamentally supported
Earnings release — direction and rough magnitude are consistent with the identified fundamental catalyst.
How unusual is this move
σ score
2.9σ
vs own 20d volatility
Percentile
98th
of 1276 daily moves
Avg daily move
±1.1%
own 5y average
vs sector
+2.5%
beyond sector median
Today’s move is among the largest 2% of GILD’s daily moves over the last 5 years — while the sector moved +1.3% and the market -0.5%.
What happened after similar moves
48 similar up moves in GILD’s 5-year history:
After 5 days
+0.5%
60% higher
After 20 days
+2.0%
62% higher
Median of same-direction moves within ±35% magnitude band. Past patterns don’t predict outcomes — context, not signal.
Fundamental context
V 62G 30P 0H 48Q 50EW 30/65
Insider activity (90d): net selling $3.09M
Valuation context
P/E (TTM)
17.2
5y median 19.2
P/E percentile
22%
vs own 5y history
FCF yield
0.1%
Trading cheaper than 78% of its own historical valuation range.
Full fundamental analysis on PreMarketPrice
Pillar scores, financial statements, valuation history, news & more for GILD